These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 33108956)
41. Opioid antagonists naloxone, beta-funaltrexamine and naltrindole, but not nor-binaltorphimine, reverse the increased hindpaw withdrawal latency in rats induced by intrathecal administration of the calcitonin gene-related peptide antagonist CGRP8-37. Yu LC; Hansson P; Lundeberg T Brain Res; 1995 Nov; 698(1-2):23-9. PubMed ID: 8581488 [TBL] [Abstract][Full Text] [Related]
42. Role of calcitonin gene-related peptide in pain regulation in the parabrachial nucleus of naive rats and rats with neuropathic pain. Wang LL; Wang HB; Fu FH; Yu LC Toxicol Appl Pharmacol; 2021 Mar; 414():115428. PubMed ID: 33524449 [TBL] [Abstract][Full Text] [Related]
43. Involvement of galanin and galanin receptor 2 in nociceptive modulation in anterior cingulate cortex of normal rats and rats with mononeuropathy. Zhang ML; Wang HB; Fu FH; Yu LC Sci Rep; 2017 Apr; 7():45930. PubMed ID: 28378856 [TBL] [Abstract][Full Text] [Related]
44. Selective modulation of tonic aversive qualities of neuropathic pain by morphine in the central nucleus of the amygdala requires endogenous opioid signaling in the anterior cingulate cortex. Navratilova E; Nation K; Remeniuk B; Neugebauer V; Bannister K; Dickenson AH; Porreca F Pain; 2020 Mar; 161(3):609-618. PubMed ID: 31725062 [TBL] [Abstract][Full Text] [Related]
45. Involvement of oxytocin in spinal antinociception in rats with inflammation. Yu SQ; Lundeberg T; Yu LC Brain Res; 2003 Sep; 983(1-2):13-22. PubMed ID: 12914962 [TBL] [Abstract][Full Text] [Related]
46. A transcriptomic analysis of neuropathic pain in the anterior cingulate cortex after nerve injury. Zhang Y; Jiang S; Liao F; Huang Z; Yang X; Zou Y; He X; Guo Q; Huang C Bioengineered; 2022 Feb; 13(2):2058-2075. PubMed ID: 35030976 [TBL] [Abstract][Full Text] [Related]
47. Galanin plays a role in antinociception via binding to galanin receptors in the nucleus accumbens of rats with neuropathic pain. Zhang Y; Gao Y; Li CY; Dong W; Li MN; Liu YN; Dong Y; Xu SL Neurosci Lett; 2019 Jul; 706():93-98. PubMed ID: 31085289 [TBL] [Abstract][Full Text] [Related]
48. Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors. Pacheco Dda F; Romero TR; Duarte ID Brain Res; 2014 May; 1562():69-75. PubMed ID: 24675031 [TBL] [Abstract][Full Text] [Related]
49. Role of spinal opioid receptor on the antiallodynic effect of intrathecal nociceptin in neuropathic rat. Ju J; Shin DJ; Na YC; Yoon MH Neurosci Lett; 2013 May; 542():118-22. PubMed ID: 23545207 [TBL] [Abstract][Full Text] [Related]
50. A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test. Noble F; Blommaert A; Fournié-Zaluski MC; Roques BP Eur J Pharmacol; 1995 Jan; 273(1-2):145-51. PubMed ID: 7737308 [TBL] [Abstract][Full Text] [Related]
51. Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant μ-opioid receptor gene in spinal cord. Kao JH; Gao MJ; Yang PP; Law PY; Loh HH; Tao PL Br J Pharmacol; 2015 Jan; 172(2):630-41. PubMed ID: 24866991 [TBL] [Abstract][Full Text] [Related]
52. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. Ward SJ; Takemori AE J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119 [TBL] [Abstract][Full Text] [Related]
53. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone. Sakurada S; Hayashi T; Yuhki M; Fujimura T; Murayama K; Yonezawa A; Sakurada C; Takeshita M; Zadina JE; Kastin AJ; Sakurada T Brain Res; 2000 Oct; 881(1):1-8. PubMed ID: 11033087 [TBL] [Abstract][Full Text] [Related]
54. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Gouardères C; Jhamandas K; Sutak M; Zajac JM Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539 [TBL] [Abstract][Full Text] [Related]
55. YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatment. Vats ID; Dolt KS; Kumar K; Karar J; Nath M; Mohan A; Pasha MA; Pasha S J Neurosci Res; 2008 May; 86(7):1599-607. PubMed ID: 18183621 [TBL] [Abstract][Full Text] [Related]
56. mu- but not delta- and kappa-opioid receptor mediates the nucleus submedius interferon-alpha-evoked antinociception in the rat. Wang JY; Zeng XY; Fan GX; Yuan YK; Tang JS Neurosci Lett; 2006 Apr; 397(3):254-8. PubMed ID: 16406668 [TBL] [Abstract][Full Text] [Related]
57. Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of Gerak LR; Minervini V; Latham E; Ghodrati S; Lillis KV; Wooden J; Disney A; Husbands SM; France CP J Pharmacol Exp Ther; 2019 Nov; 371(2):507-516. PubMed ID: 31439807 [TBL] [Abstract][Full Text] [Related]
58. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa. Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601 [TBL] [Abstract][Full Text] [Related]
59. The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception. Sánchez-Blázquez P; Cortés-Montero E; Rodríguez-Muñoz M; Merlos M; Garzón-Niño J Mol Brain; 2020 Nov; 13(1):150. PubMed ID: 33176836 [TBL] [Abstract][Full Text] [Related]
60. Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain. Nielsen CK; Ross FB; Lotfipour S; Saini KS; Edwards SR; Smith MT Pain; 2007 Dec; 132(3):289-300. PubMed ID: 17467904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]